Growth Metrics

CorMedix (CRMD) Change in Receivables (2016 - 2025)

CorMedix has reported Change in Receivables over the past 10 years, most recently at $12.4 million for Q4 2025.

  • Quarterly results put Change in Receivables at $12.4 million for Q4 2025, down 63.97% from a year ago — trailing twelve months through Dec 2025 was $90.9 million (up 76.26% YoY), and the annual figure for FY2025 was $90.9 million, up 75.56%.
  • Change in Receivables reached $12.4 million in Q4 2025 per CRMD's latest filing, down from $87.3 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $87.3 million in Q3 2025 and bottomed at -$11.7 million in Q2 2025.
  • Median Change in Receivables over the past 4 years was $21337.0 (2021), compared with a mean of $10.2 million.
  • Peak annual rise in Change in Receivables hit 1825.73% in 2021, while the deepest fall reached 1290.7% in 2021.
  • Over 4 years, Change in Receivables stood at $47354.0 in 2021, then tumbled by 99.07% to $440.0 in 2022, then skyrocketed by 7818889.55% to $34.4 million in 2024, then crashed by 63.97% to $12.4 million in 2025.
  • Business Quant data shows Change in Receivables for CRMD at $12.4 million in Q4 2025, $87.3 million in Q3 2025, and -$11.7 million in Q2 2025.